A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes
2019 · Nature Communications · 86 citations
https://doi.org/10.1038/s41467-019-09143-8
R
Robert Nakayama
Keio University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
159
Papers
2.8K
Citations
27
h-index
53
i10-index
Robert Nakayama is an academic researcher from Keio University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Bone Tumor Diagnosis and Treatments & Vascular Tumors and Angiosarcomas. The author has an h-index of 27, co-authored 136 publications.
ORCID: 0000-0003-1985-2169Papers by this author
worksClinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy
2018 · BMC Cancer · 39 citations
https://doi.org/10.1186/s12885-018-5188-6
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1
2022 · International Journal of Clinical Oncology · 38 citations
https://doi.org/10.1007/s10147-021-02081-w
CT guided cryoablation for locally recurrent or metastatic bone and soft tissue tumor: initial experience
2016 · BMC Cancer · 34 citations
https://doi.org/10.1186/s12885-016-2852-6
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2
2022 · International Journal of Clinical Oncology · 29 citations
https://doi.org/10.1007/s10147-021-02076-7
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway
2020 · Diagnostic Pathology · 28 citations
https://doi.org/10.1186/s13000-020-01004-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat